Editorial Note on Metabolic Syndrome.
Fleur Delacour
Abstract
Fleur Delacour
Abstract
One of the most common causes of atherosclerotic vascular disease and type 2 diabetes is metabolic syndrome (MS) (Type 2 DM). Metabolic syndrome is characterised by abdominal obesity, insulin resistance, high blood pressure, and lipid disorders. The metabolic syndrome's prevalence rises with age and body weight, as well as through populations studied at the same time. The prevalence of metabolic syndrome is 27 percent in the United States, and the prevalence of metabolic syndrome is growing faster in women. In Turkey, metabolic syndrome affects 38% of the population.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
One of the most common causes of atherosclerotic vascular disease and type 2 diabetes is metabolic syndrome (MS) (Type 2 DM). Metabolic syndrome is characterised by abdominal obesity, insulin resistance, high blood pressure, and lipid disorders. The metabolic syndrome's prevalence rises with age and body weight, as well as through populations studied at the same time. The prevalence of metabolic syndrome is 27 percent in the United States, and the prevalence of metabolic syndrome is growing faster in women. In Turkey, metabolic syndrome affects 38% of the population.
Key concepts: Metabolic syndrome, Insulin resistance, Medicine, Obesity, Type 2 diabetes, Abdominal obesity, Internal medicine, Endocrinology